Krognes Steve E. 4

What Happened

• Steve E. Krognes, a director of Guardant Health (GH), reported conversion/exercise of restricted stock units (transaction code M) on February 28, 2026. The filing shows 154 shares were acquired at $0.00 and a corresponding derivative (the RSU) was removed (154 shares, $0.00). No cash changed hands — this reflects RSU vesting and conversion to common shares rather than a market purchase or sale.

Key Details

• Transaction date: 2026-02-28; Form 4 filed: 2026-03-02 (no late filing indicated).
• Reported amounts/prices: 154 shares acquired @ $0.00; 154-share derivative disposed @ $0.00 (code M = exercise/conversion).
• Shares owned after transaction: not disclosed in the provided filing details.
• Footnotes: F1 — these shares come from an RSU grant dated Aug 9, 2022 that vested 25% on June 30, 2023 with the remaining 75% vesting in substantially equal monthly installments over the following three years. F2 — not applicable for RSUs.
• Interpretation: This is routine vesting/conversion of an equity award, not an open-market buy or sale.

Context

• For retail investors: vested RSUs converting to shares are common compensation events and generally do not signal a change in insider sentiment by themselves. The transaction code M indicates conversion/exercise of a derivative (the RSU) into underlying shares; the paired acquisition and derivative disposal entries reflect the RSU being settled into common stock.